WALLEN WILLIAM C 4
4 · IDEXX LABORATORIES INC /DE · Filed Aug 25, 2009
Insider Transaction Report
Form 4
WALLEN WILLIAM C
Senior Vice President
Transactions
- Sale
Common Stock
2009-08-21$50.85/sh−18,381$934,674→ 18,614 total - Sale
Common Stock
2009-08-24$50.80/sh−1,619$82,245→ 18,614 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2009-08-21−18,381→ 25,149 totalExercise: $21.30Exp: 2013-09-08→ Common Stock (18,381 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2009-08-24−1,619→ 23,530 totalExercise: $21.30Exp: 2013-09-08→ Common Stock (1,619 underlying) - Exercise/Conversion
Common Stock
2009-08-21$21.30/sh+18,381$391,515→ 36,995 total - Exercise/Conversion
Common Stock
2009-08-24$21.30/sh+1,619$34,485→ 20,233 total
Footnotes (2)
- [F1]The sale price reported above reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged between $50.80 and $51.05. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- [F2]Grant of options to buy shares of Common Stock exercisable in five equal annual increments, beginning on the first anniversary date (09/08/2004) of the date of the grant.